论文部分内容阅读
急性脑梗塞治疗上目前尚无突破性进展,但是早期溶栓使血管再通是终止脑缺血软化、降低致残率的理想方法。我们采用尿激酶经颈内动脉直接注射给药治疗急性脑梗塞,收到显著疗效,现报告如下。 1 临床资料 1.1病例选择:动脉溶栓组32例,男19例,女13例,年龄46～75岁,平均57.5岁。静脉溶栓组30例,男18例,女12例,年龄44～79岁,平均58.5岁;常规治疗组29例,男18例,女11例,年龄47～78岁,平均59.5岁。所有病人均按1986年第二次全国脑血管病学术会议第3次修订的各类脑血管病诊断标准,并经头颅CT检查排除了脑出血,发病12小时以内,夫溶栓禁忌症,临床诊断为颈内动脉系统脑
There are no breakthroughs in the treatment of acute cerebral infarction. However, early thrombolysis makes recanalization the ideal method to stop cerebral ischemia and soften and reduce the morbidity. We use urokinase injection via the internal carotid artery injection of acute cerebral infarction, received a significant effect, are as follows. 1 Clinical data 1.1 Case Selection: Thrombolytic group of 32 cases, 19 males and 13 females, aged 46 to 75 years, mean 57.5 years old. Thrombolytic group of 30 patients, 18 males and 12 females, aged 44 to 79 years, mean 58.5 years; conventional treatment group 29 cases, 18 males and 11 females, aged 47 to 78 years, mean 59.5 years. All patients according to the second national cerebrovascular disease conference in 1986 the third revision of the various types of cerebrovascular disease diagnostic criteria, and by skull CT examination to rule out cerebral hemorrhage, the incidence of 12 hours, fu thrombolysis contraindications, clinical Diagnosis of internal carotid artery system brain